Medicare began covering telemedicine services during the COVID-19 pandemic and has maintained the popular offering through temporary waivers approved by Congress since
I guess now is not a good time for my sinus infection to return. 😾
Medicare began covering telemedicine services during the COVID-19 pandemic and has maintained the popular offering through temporary waivers approved by Congress since
I guess now is not a good time for my sinus infection to return. 😾

I am amusing myself with watching the panic some people express over Elon Musk’s cleanup of Twitter.
Yesterday 3,700 of its 7,500 workers were fired. That is not good, but the company was losing money and making money is at the core of the capitalist game.
The Twitter Massacre
The yellow press is raving that “Putin is going to annex”. They care zero about people. They are apparently not human because they do not hate Russia. Donbas is a “land without people” to NATO and the US. As is Crimea or Kherson.
“PUTIN IS GOING TO ANNEX” — in human language, that means protect the population from extermination
Related:
Alexei Zhuravko – A rebellious opposition politician assassinated by the Kiev regime
32 Years After US Disabilities Act, No Plans to Ratify UN Treaty It Inspired
The administration says it supports “disability-inclusive development and humanitarian action” around the world.
Links to:
USAID Announces Commitments at the Global Disability Summit:
In keeping with the “Year of Action” for disability-inclusive democracy stemming from the Summit for Democracy, USAID will support the empowerment of persons with disabilities and their representative organizations to be active participants in civic engagement and the political and public life of their countries.
USAID is weaponizing disability rights for regime change!
The largest-ever Medicare premium increase will pad the pockets of insurance executives who donated millions to the president’s election campaign.
Biden Hikes Medicare Prices And Funnels Profits to Private Insurers
Related:
Medicare limits coverage of controversial Alzheimer’s drug to those in clinical trials
You must be logged in to post a comment.